Zoetis (XSWX:ZTS) Buildings And Improvements: CHF0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:ZTS Zoetis Inc XSWX:ZTS
56 GF Score
Price CHF61.26
GF Value CHF147.84
Valuation Significantly Undervalued
View Full Analysis

What is Zoetis Buildings And Improvements?

Zoetis XSWX:ZTS 56 Buildings And Improvements is CHF0 Mil as of Jun. 2026. GuruFocus rates XSWX:ZTS with a GF Score™ of 56/100 and a GF Value™ of CHF147.84 (Significantly Undervalued).

Zoetis's quarterly buildings and improvements declined from Dec. 2025 (CHF1,234 Mil) to Mar. 2026 (CHF0 Mil) but then stayed the same from Mar. 2026 (CHF0 Mil) to Jun. 2026 (CHF0 Mil).

Zoetis's annual buildings and improvements increased from Dec. 2023 (CHF1,138 Mil) to Dec. 2024 (CHF1,152 Mil) and increased from Dec. 2024 (CHF1,152 Mil) to Dec. 2025 (CHF1,234 Mil).

Zoetis Buildings And Improvements Historical Data

* Premium members only.

The historical data trend for Zoetis's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zoetis Buildings And Improvements Chart

Zoetis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buildings And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,015.86 1,115.13 1,138.08 1,151.95 1,234.40

Zoetis Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 1,234.40 0.00 0.00
XSWX:ZTS
56GF Score
Zoetis Inc XSWX:ZTS
Buildings And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zoetis Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

What does a Buildings And Improvements of CHF0 Mil mean?
Zoetis (XSWX:ZTS) has a Buildings And Improvements of CHF0 Mil as of Jun. 2026. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on Zoetis and its competitors.
Is Zoetis' Buildings And Improvements too high?
Zoetis' current Buildings And Improvements is CHF0 Mil. Overall, Zoetis has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zoetis' Buildings And Improvements compare to UTHR and VTRS?
Zoetis' Buildings And Improvements of CHF0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buildings And Improvements for a Drug Manufacturers company?
A good Buildings And Improvements depends on the Drug Manufacturers industry context. However, Buildings And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buildings And Improvements mean?
A high Buildings And Improvements can signal that a stock is expensive relative to its fundamentals. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on Zoetis and its competitors. Zoetis's current Buildings And Improvements is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zoetis stock overvalued right now?
Based on GuruFocus' analysis, Zoetis (XSWX:ZTS) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF147.84, compared to a current price of CHF61.26 — trading 58.6% below its estimated fair value. The current Buildings And Improvements is CHF0 Mil. Zoetis' overall GF Score™ is 56/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buildings And Improvements calculated?
Buildings And Improvements is calculated from a company's financial statements. For Zoetis (XSWX:ZTS), the current Buildings And Improvements is CHF0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zoetis (XSWX:ZTS) Overvalued in 2026?

Based on GuruFocus' analysis, Zoetis stock appears to be undervalued. The current stock price of CHF61.26 is trading 58.6% below its estimated GF Value™ of CHF147.84. GuruFocus considers Zoetis to be Significantly Undervalued.

Key valuation signals for XSWX:ZTS:

  • Buildings And Improvements: CHF0 Mil
  • GF Value™: CHF147.84 vs. price of CHF61.26 (58.6% below fair value)
  • GF Score™: 56/100

No single metric tells the full story. See the XSWX:ZTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zoetis Business Description

Address 10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
56GF Score

Get the complete analysis for XSWX:ZTS

Buildings And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF61.26
Price
CHF147.84
GF Value